vs

Side-by-side financial comparison of Indivior Pharmaceuticals, Inc. (INDV) and Cactus, Inc. (WHD). Click either name above to swap in a different company.

Indivior Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($357.0M vs $261.2M, roughly 1.4× Cactus, Inc.). Indivior Pharmaceuticals, Inc. runs the higher net margin — 28.9% vs 18.5%, a 10.4% gap on every dollar of revenue.

Indivior is a global specialty pharmaceutical company dedicated to developing and commercializing evidence-based treatments for substance use disorders such as opioid use disorder and alcohol dependence, as well as related mental health conditions. Its primary operating markets are North America and Europe, with a portfolio of approved therapies targeting unmet medical needs for underserved patient groups.

Cactus Club Cafe is a Canadian-owned chain of premium casual restaurants that originated in North Vancouver, British Columbia. The chain has since expanded to 34 locations throughout Canada, with other locations throughout British Columbia, Alberta, Saskatchewan, Ontario and the United States

INDV vs WHD — Head-to-Head

Bigger by revenue
INDV
INDV
1.4× larger
INDV
$357.0M
$261.2M
WHD
Higher net margin
INDV
INDV
10.4% more per $
INDV
28.9%
18.5%
WHD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INDV
INDV
WHD
WHD
Revenue
$357.0M
$261.2M
Net Profit
$103.0M
$48.3M
Gross Margin
82.1%
Operating Margin
22.7%
18.6%
Net Margin
28.9%
18.5%
Revenue YoY
-4.0%
Net Profit YoY
390.5%
-15.9%
EPS (diluted)
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDV
INDV
WHD
WHD
Q1 26
$261.2M
Q4 25
$357.0M
$261.2M
Q3 25
$314.0M
$264.0M
Q2 25
$302.0M
$273.6M
Q1 25
$266.0M
$280.3M
Q4 24
$272.1M
Q3 24
$307.0M
$293.2M
Q2 24
$299.0M
$290.4M
Net Profit
INDV
INDV
WHD
WHD
Q1 26
$48.3M
Q4 25
$103.0M
$39.8M
Q3 25
$42.0M
$41.6M
Q2 25
$18.0M
$40.3M
Q1 25
$47.0M
$44.2M
Q4 24
$46.7M
Q3 24
$22.0M
$49.9M
Q2 24
$-97.0M
$49.8M
Gross Margin
INDV
INDV
WHD
WHD
Q1 26
Q4 25
82.1%
36.2%
Q3 25
73.2%
36.8%
Q2 25
82.8%
36.6%
Q1 25
83.1%
38.4%
Q4 24
37.8%
Q3 24
78.5%
39.0%
Q2 24
73.6%
39.2%
Operating Margin
INDV
INDV
WHD
WHD
Q1 26
18.6%
Q4 25
22.7%
22.9%
Q3 25
13.7%
23.2%
Q2 25
23.8%
22.2%
Q1 25
24.8%
24.5%
Q4 24
25.9%
Q3 24
11.4%
26.2%
Q2 24
-39.5%
27.5%
Net Margin
INDV
INDV
WHD
WHD
Q1 26
18.5%
Q4 25
28.9%
15.3%
Q3 25
13.4%
15.8%
Q2 25
6.0%
14.7%
Q1 25
17.7%
15.8%
Q4 24
17.2%
Q3 24
7.2%
17.0%
Q2 24
-32.4%
17.2%
EPS (diluted)
INDV
INDV
WHD
WHD
Q1 26
Q4 25
$0.79
Q3 25
$0.33
Q2 25
$0.14
Q1 25
$0.38
Q4 24
Q3 24
$0.16
Q2 24
$-0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDV
INDV
WHD
WHD
Cash + ST InvestmentsLiquidity on hand
$195.0M
$123.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-98.0M
$1.4B
Total Assets
$1.2B
$1.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDV
INDV
WHD
WHD
Q1 26
$123.6M
Q4 25
$195.0M
$123.6M
Q3 25
$445.0M
$445.6M
Q2 25
$510.0M
$405.2M
Q1 25
$373.0M
$347.7M
Q4 24
$342.8M
Q3 24
$303.4M
Q2 24
$246.5M
Total Debt
INDV
INDV
WHD
WHD
Q1 26
Q4 25
$0
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Stockholders' Equity
INDV
INDV
WHD
WHD
Q1 26
$1.4B
Q4 25
$-98.0M
$1.2B
Q3 25
$-207.0M
$1.2B
Q2 25
$-257.0M
$1.1B
Q1 25
$-285.0M
$1.1B
Q4 24
$1.1B
Q3 24
$-310.0M
$1.0B
Q2 24
$-281.0M
$954.7M
Total Assets
INDV
INDV
WHD
WHD
Q1 26
$1.9B
Q4 25
$1.2B
$1.9B
Q3 25
$1.4B
$1.9B
Q2 25
$1.5B
$1.8B
Q1 25
$1.4B
$1.8B
Q4 24
$1.7B
Q3 24
$1.7B
Q2 24
$1.6B
Debt / Equity
INDV
INDV
WHD
WHD
Q1 26
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDV
INDV
WHD
WHD
Operating Cash FlowLast quarter
$-221.0M
$258.4M
Free Cash FlowOCF − Capex
$-245.0M
FCF MarginFCF / Revenue
-68.6%
Capex IntensityCapex / Revenue
6.7%
14.9%
Cash ConversionOCF / Net Profit
-2.15×
5.35×
TTM Free Cash FlowTrailing 4 quarters
$-93.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDV
INDV
WHD
WHD
Q1 26
$258.4M
Q4 25
$-221.0M
$72.3M
Q3 25
$-39.0M
$61.8M
Q2 25
$158.0M
$82.8M
Q1 25
$75.0M
$41.5M
Q4 24
$66.6M
Q3 24
$2.0M
$85.3M
Q2 24
$88.0M
$78.0M
Free Cash Flow
INDV
INDV
WHD
WHD
Q1 26
Q4 25
$-245.0M
Q3 25
$-59.0M
Q2 25
$141.0M
Q1 25
$70.0M
Q4 24
Q3 24
$-5.0M
Q2 24
$84.0M
FCF Margin
INDV
INDV
WHD
WHD
Q1 26
Q4 25
-68.6%
Q3 25
-18.8%
Q2 25
46.7%
Q1 25
26.3%
Q4 24
Q3 24
-1.6%
Q2 24
28.1%
Capex Intensity
INDV
INDV
WHD
WHD
Q1 26
14.9%
Q4 25
6.7%
Q3 25
6.4%
Q2 25
5.6%
Q1 25
1.9%
Q4 24
Q3 24
2.3%
Q2 24
1.3%
Cash Conversion
INDV
INDV
WHD
WHD
Q1 26
5.35×
Q4 25
-2.15×
1.81×
Q3 25
-0.93×
1.48×
Q2 25
8.78×
2.05×
Q1 25
1.60×
0.94×
Q4 24
1.43×
Q3 24
0.09×
1.71×
Q2 24
1.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INDV
INDV

Sublocade$233.0M65%
Sublingual And Other$69.0M19%
Other$49.0M14%
Perseris$6.0M2%

WHD
WHD

Revenue$178.4M68%
Other$82.8M32%

Related Comparisons